CFDA approval has been given too much valuation in Australia.
Chinese infant formula company, BeingMate (Market cap: A$1b) which is in partnership with Fonterra (is also second largest shareholder of BeingMate), received first CFDA approval last August, now BeingMate has received CFDA approval for 39 infant formula formulations(/steps), but it’s valued at A$1b.
At 100% basis, JAT was valued over $200m at 23c/share, it’s too much imo.
JAT Chart & TA Discussions, page-668
Add JAT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
51.0¢ |
Change
0.020(4.08%) |
Mkt cap ! $42.46M | |||
| Open | High | Low | Value | Volume |
| 49.5¢ | 51.0¢ | 49.0¢ | $12.85K | 25.77K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 96 | 51.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 55.0¢ | 39565 | 1 |
View Market Depth
| Last trade - 13.43pm 06/11/2024 (20 minute delay) ? |
| JAT (ASX) Chart |